3M Capital hip arthroplasty: 3-8-year follow-up of 208 primary hip replacements

Insights

Capital hip replacements showed a lower failure rate than expected, with aseptic loosening affecting 4% of revised hips. Design is not the sole factor in loosening, highlighting the need for ongoing clinical data registration.

Area of Science:

  • Orthopedic surgery
  • Biomaterials science
  • Medical device engineering

Background:

  • The Capital hip prosthesis was subject to patient recall in 1998 due to reported failures.
  • Understanding the long-term performance and failure modes of recalled implants is crucial for patient safety and future designs.

Purpose of the Study:

  • To evaluate the clinical outcomes and failure rates of the recalled Capital hip prosthesis.
  • To identify factors associated with loosening and revision surgery in this cohort.

Main Methods:

  • Retrospective review of 267 Capital hip replacements.
  • Follow-up of 208 hips (200 patients) for an average of 6 years post-implantation.
  • Radiographic and clinical assessment for aseptic loosening and revision surgery.

Main Results:

  • 9 hips (4%) required revision due to aseptic loosening.
  • 10 stems (5%) were identified as radiographically loose.
  • A higher incidence of loosening was observed in males and with both varus and valgus stem designs.

Conclusions:

  • The observed failure rate for the Capital hip prosthesis was lower than previously published figures.
  • Factors beyond implant design, such as patient-specific characteristics and surgical technique, likely influence loosening.
  • Continuous large-scale registration of clinical data and outcome parameters is recommended for comprehensive implant surveillance.

Related Concept Videos